On episode #270 of the science show This Week in Virology, Vincent and Rich discuss avian influenza virus and an antiviral drug against smallpox with Dennis and Yoshi at the ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC. You can find TWiV #270 at www.microbe.tv/twiv.
On episode #253 of the science show This Week in Virology, the complete TWiV team reads questions and comments from listeners about systemic antiviral responses, wild type poliovirus in Israel, Turkish scientists, viral symbiotes, and much more. You can find TWiV #253 at www.microbe.tv/twiv.
Episode #235 of the science show This Week in Virology was recorded before an audience at the 2nd Li Ka Shing Institute of Virology Symposium at the University of Alberta, where they spoke with Dave, Stan, and Lorne about their work on poxvirus vaccines and recombination, an enveloped picornavirus, antivirals against hepatitis B and C viruses, …
Hosts: Vincent Racaniello and Dickson Despommier Vincent and Dickson have a broad-ranging conversation with Charles Knirsch of Pfizer, Inc. about how public-private partnerships can function to control and eliminate infectious diseases. [powerpress url=”http://traffic.libsyn.com/twip/TWiP030.mp3″] Click the arrow above to play, or right-click to download TWiP #30 (61 MB .mp3, 85 minutes). Links for this episode: Ivan’s images (one, two, three, …
TWiP 30: Global infectious disease control with Charles Knirsch Read More »
Hosts: Vincent Racaniello, Rich Condit, and Abbie Smith Vincent, Rich, and Abbie review a broad spectrum antiviral protein, and selective pressure applied by a failed HIV-1 vaccine. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV146.mp3″] Click the arrow above to play, or right-click to download TWiV 146 (78 MB .mp3, 107 minutes). Subscribe to TWiV (free) in iTunes , at the Zune …
Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Vincent, Alan, and Rich discuss growth in culture of newly identified rhinovirus C, vaccinia transmission among wrestlers and martial artists, and results of phase III clinical trial of boceprevir, a new inhibitor of hepatitis C virus replication. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV130.mp3″] Click the arrow above to play, or right-click to download …
TWiV 130: Rhino tracking, wrestling pox, and HCV in the crosshairs Read More »
